Hemoglobinopathies Market Size, Share, Growth, and Industry Analysis, By Type (Blood Transfusion, Iron Chelation Therapy, Bone Marrow Transplant, Others), By Application (Blood Testing, Genetic Testing, Pre-Implantation Genetic Diagnosis (PGD), Others), Regional Insights and Forecast to 2035
Detailed TOC of Global Hemoglobinopathies Market Research Report 2024
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemoglobinopathies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blood Transfusion
1.2.3 Iron Chelation Therapy
1.2.4 Bone Marrow Transplant
1.2.5 Others
1.3 Market by Application
1.3.1 Global Hemoglobinopathies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Blood Testing
1.3.3 Genetic Testing
1.3.4 Pre-Implantation Genetic Diagnosis (PGD)
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hemoglobinopathies Market Perspective (2019-2030)
2.2 Hemoglobinopathies Growth Trends by Region
2.2.1 Global Hemoglobinopathies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hemoglobinopathies Historic Market Size by Region (2019-2024)
2.2.3 Hemoglobinopathies Forecasted Market Size by Region (2025-2030)
2.3 Hemoglobinopathies Market Dynamics
2.3.1 Hemoglobinopathies Industry Trends
2.3.2 Hemoglobinopathies Market Drivers
2.3.3 Hemoglobinopathies Market Challenges
2.3.4 Hemoglobinopathies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemoglobinopathies Players by Revenue
3.1.1 Global Top Hemoglobinopathies Players by Revenue (2019-2024)
3.1.2 Global Hemoglobinopathies Revenue Market Share by Players (2019-2024)
3.2 Global Hemoglobinopathies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hemoglobinopathies Revenue
3.4 Global Hemoglobinopathies Market Concentration Ratio
3.4.1 Global Hemoglobinopathies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemoglobinopathies Revenue in 2023
3.5 Hemoglobinopathies Key Players Head office and Area Served
3.6 Key Players Hemoglobinopathies Product Solution and Service
3.7 Date of Enter into Hemoglobinopathies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemoglobinopathies Breakdown Data by Type
4.1 Global Hemoglobinopathies Historic Market Size by Type (2019-2024)
4.2 Global Hemoglobinopathies Forecasted Market Size by Type (2025-2030)
5 Hemoglobinopathies Breakdown Data by Application
5.1 Global Hemoglobinopathies Historic Market Size by Application (2019-2024)
5.2 Global Hemoglobinopathies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hemoglobinopathies Market Size (2019-2030)
6.2 North America Hemoglobinopathies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hemoglobinopathies Market Size by Country (2019-2024)
6.4 North America Hemoglobinopathies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hemoglobinopathies Market Size (2019-2030)
7.2 Europe Hemoglobinopathies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hemoglobinopathies Market Size by Country (2019-2024)
7.4 Europe Hemoglobinopathies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hemoglobinopathies Market Size (2019-2030)
8.2 Asia-Pacific Hemoglobinopathies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hemoglobinopathies Market Size by Region (2019-2024)
8.4 Asia-Pacific Hemoglobinopathies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hemoglobinopathies Market Size (2019-2030)
9.2 Latin America Hemoglobinopathies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hemoglobinopathies Market Size by Country (2019-2024)
9.4 Latin America Hemoglobinopathies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemoglobinopathies Market Size (2019-2030)
10.2 Middle East & Africa Hemoglobinopathies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hemoglobinopathies Market Size by Country (2019-2024)
10.4 Middle East & Africa Hemoglobinopathies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gamida Cell
11.1.1 Gamida Cell Company Detail
11.1.2 Gamida Cell Business Overview
11.1.3 Gamida Cell Hemoglobinopathies Introduction
11.1.4 Gamida Cell Revenue in Hemoglobinopathies Business (2019-2024)
11.1.5 Gamida Cell Recent Development
11.2 Alnylam Pharmaceuticals
11.2.1 Alnylam Pharmaceuticals Company Detail
11.2.2 Alnylam Pharmaceuticals Business Overview
11.2.3 Alnylam Pharmaceuticals Hemoglobinopathies Introduction
11.2.4 Alnylam Pharmaceuticals Revenue in Hemoglobinopathies Business (2019-2024)
11.2.5 Alnylam Pharmaceuticals Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Hemoglobinopathies Introduction
11.3.4 Sanofi Revenue in Hemoglobinopathies Business (2019-2024)
11.3.5 Sanofi Recent Development
11.4 Sangamo Therapeutics Inc.
11.4.1 Sangamo Therapeutics Inc. Company Detail
11.4.2 Sangamo Therapeutics Inc. Business Overview
11.4.3 Sangamo Therapeutics Inc. Hemoglobinopathies Introduction
11.4.4 Sangamo Therapeutics Inc. Revenue in Hemoglobinopathies Business (2019-2024)
11.4.5 Sangamo Therapeutics Inc. Recent Development
11.5 Global Blood Therapeutics
11.5.1 Global Blood Therapeutics Company Detail
11.5.2 Global Blood Therapeutics Business Overview
11.5.3 Global Blood Therapeutics Hemoglobinopathies Introduction
11.5.4 Global Blood Therapeutics Revenue in Hemoglobinopathies Business (2019-2024)
11.5.5 Global Blood Therapeutics Recent Development
11.6 Bluebird Bio
11.6.1 Bluebird Bio Company Detail
11.6.2 Bluebird Bio Business Overview
11.6.3 Bluebird Bio Hemoglobinopathies Introduction
11.6.4 Bluebird Bio Revenue in Hemoglobinopathies Business (2019-2024)
11.6.5 Bluebird Bio Recent Development
11.7 Emmaus Life Sciences Inc.
11.7.1 Emmaus Life Sciences Inc. Company Detail
11.7.2 Emmaus Life Sciences Inc. Business Overview
11.7.3 Emmaus Life Sciences Inc. Hemoglobinopathies Introduction
11.7.4 Emmaus Life Sciences Inc. Revenue in Hemoglobinopathies Business (2019-2024)
11.7.5 Emmaus Life Sciences Inc. Recent Development
11.8 Prolong Pharmaceuticals
11.8.1 Prolong Pharmaceuticals Company Detail
11.8.2 Prolong Pharmaceuticals Business Overview
11.8.3 Prolong Pharmaceuticals Hemoglobinopathies Introduction
11.8.4 Prolong Pharmaceuticals Revenue in Hemoglobinopathies Business (2019-2024)
11.8.5 Prolong Pharmaceuticals Recent Development
11.9 Celgene Corporation
11.9.1 Celgene Corporation Company Detail
11.9.2 Celgene Corporation Business Overview
11.9.3 Celgene Corporation Hemoglobinopathies Introduction
11.9.4 Celgene Corporation Revenue in Hemoglobinopathies Business (2019-2024)
11.9.5 Celgene Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details